Nicotinic Antagonists

Nicotinic Antagonist is a pharmacological agent that selectively inhibits nicotinic acetylcholine receptors, thereby blocking neurotransmission mediated by acetylcholine at nicotinic synapses in the autonomic nervous system and neuromuscular junction.

1.5K

Publications

82.6K

Citations

4.9K

Authors

1.1K

Institutions

Publications per year

2017–2026

91

Variants

Nicotinic Cholinergic AntagonistsNicotinic Receptor Antagonists

Authors

4.9K

  1. JM
    J. Michael McIntosh

    University of Utah, United States

    45 publications · 2.5K citations

    30

    h-index

  2. PA
    Peter A. Crooks

    University of Kentucky, United States

    37 publications · 1.4K citations

    25

    h-index

  3. LP
    Linda P. Dwoskin

    University of Kentucky, United States

    36 publications · 1.4K citations

    24

    h-index

  4. ED
    Edward D. Levin

    Duke Medical Center, United States

    28 publications · 1.4K citations

    22

    h-index

  5. BR
    Billy R. Martin

    Virginia Commonwealth University Medical Center, United States

    20 publications · 1.6K citations

    16

    h-index

1–5 of 4.9K

Venues

  1. 45

    h-index

  2. Journal of Neuroscience

    60 publications · 6.5K citations

    45

    h-index

  3. Psychopharmacology

    60 publications · 4K citations

    38

    h-index

  4. British Journal of Pharmacology

    BJP · 62 publications · 2.8K citations

    34

    h-index

  5. Journal of Neurochemistry

    JNC · 44 publications · 4.5K citations

    33

    h-index

1–5